| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Anne Saulin, Markus Savli, Rupert Lanzenberge. Serotonin and molecular neuroimaging in humans using PET. Amino acids. vol 42. issue 6. 2012-09-10. PMID:21947614. |
the serotonergic system is one of the most important modulatory neurotransmitter systems in the human brain. |
2012-09-10 |
2023-08-12 |
human |
| Manfred Ackenheil, Klaus Webe. Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects. Dialogues in clinical neuroscience. vol 6. issue 1. 2012-09-10. PMID:22034253. |
a combined analysis of genetic polymorphisms in the dopaminergic and serotonergic receptors, neurotransmitter transporters, and other target structures involved in psychiatric disorders is already a powerful predictor of therapeutic outcome. |
2012-09-10 |
2023-08-12 |
Not clear |
| Franz Müller-Spah. Behavioral disturbances in dementia. Dialogues in clinical neuroscience. vol 5. issue 1. 2012-09-10. PMID:22034255. |
neurodegenerative processes in various brain areas, particularly in the frontotemporal cortex and limbic regions, leading to cholinergic, serotonergic, and noradrenergic neurotransmitter dysfunctions constitute the biological matrix of behavioral symptoms, whereas psychological factors and personality traits play a modifying role. |
2012-09-10 |
2023-08-12 |
Not clear |
| Marjolein B Aerts, Rianne A J Esselink, Jugen A H R Claassen, Wilson Farid Abdo, Bastiaan R Bloem, Marcel M Verbee. CSF tau, Aβ42, and MHPG differentiate dementia with Lewy bodies from Alzheimer's disease. Journal of Alzheimer's disease : JAD. vol 27. issue 2. 2012-08-16. PMID:21841257. |
since deficits in serotonergic and dopaminergic pathways seem more pronounced in dlb patients, we investigated whether cerebrospinal fluid (csf) analysis of neurotransmitter metabolites, in addition to brain-specific proteins, may improve the differentiation between dlb and ad. |
2012-08-16 |
2023-08-12 |
Not clear |
| Ulla Benedichte Knor. The effect of selective serotonin reuptake inhibitors in healthy first-degree relatives of patients with major depressive disorder - an experimental medicine blinded controlled trial. Danish medical journal. vol 59. issue 4. 2012-08-02. PMID:22459724. |
the serotonergic neurotransmitter system and the hypothalamic-pituitary-adrenal (hpa) system may interact. |
2012-08-02 |
2023-08-12 |
Not clear |
| Ulla Benedichte Knor. The effect of selective serotonin reuptake inhibitors in healthy first-degree relatives of patients with major depressive disorder - an experimental medicine blinded controlled trial. Danish medical journal. vol 59. issue 4. 2012-08-02. PMID:22459724. |
further, the serotonergic neurotransmitter system seems closely linked to personality and cognition. |
2012-08-02 |
2023-08-12 |
Not clear |
| Ulla Knorr, Maj Vinberg, Erik Lykke Mortensen, Per Winkel, Christian Gluud, Jørn Wetterslev, Ulrik Gether, Lars Vedel Kessin. Effect of chronic escitalopram versus placebo on personality traits in healthy first-degree relatives of patients with depression: a randomized trial. PloS one. vol 7. issue 2. 2012-07-23. PMID:22393376. |
the serotonergic neurotransmitter system is closely linked to depression and personality traits. |
2012-07-23 |
2023-08-12 |
Not clear |
| Toru Kobayashi, Kazuo Washiyama, Kazutaka Iked. Inhibition of G protein-activated inwardly rectifying K+ channels by different classes of antidepressants. PloS one. vol 6. issue 12. 2012-07-20. PMID:22164246. |
in addition to their primary effects on serotonergic or noradrenergic neurotransmitter systems, antidepressants have been shown to interact with several receptors and ion channels. |
2012-07-20 |
2023-08-12 |
xenopus_laevis |
| Michael Camilleri, David A Katzk. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome. American journal of physiology. Gastrointestinal and liver physiology. vol 302. issue 10. 2012-07-20. PMID:22403795. |
specific examples of the associations of genetic variation and symptoms, syndromes, and intermediate phenotypes, including neurotransmitter (serotonergic, α(2)-adrenergic, and cannabinoid) mechanisms, inflammatory pathways (il-10, tnfα, gnβ3, and susceptibility loci involved in crohn's disease), and bile acid metabolism, are explored. |
2012-07-20 |
2023-08-12 |
Not clear |
| Toru Baba, Atsushi Taked. [Recent advances in imaging in Parkinson disease]. Brain and nerve = Shinkei kenkyu no shinpo. vol 64. issue 4. 2012-06-21. PMID:22481515. |
moreover, radiotracer imaging with dopaminergic markers facilitates the assessment of pre- and postsynaptic nigro-striatal integrity, and other radiotracers have been used in the studies of nondopaminergic neurotransmitter systems, such as the cholinergic, noradrenergic, and serotonergic systems. |
2012-06-21 |
2023-08-12 |
Not clear |
| Jessica Johansson, Magnus Landgren, Elisabeth Fernell, Ravi Vumma, Arne Åhlin, Lars Bjerkenstedt, Nikolaos Venizelo. Altered tryptophan and alanine transport in fibroblasts from boys with attention-deficit/hyperactivity disorder (ADHD): an in vitro study. Behavioral and brain functions : BBF. vol 7. 2012-05-25. PMID:21942982. |
the catecholaminergic and serotonergic neurotransmitter systems are implicated in the pathophysiology of attention-deficit/hyperactivity disorder (adhd). |
2012-05-25 |
2023-08-12 |
Not clear |
| S Josefin Dahlbom, Tobias Backström, Katrin Lundstedt-Enkel, Svante Winber. Aggression and monoamines: effects of sex and social rank in zebrafish (Danio rerio). Behavioural brain research. vol 228. issue 2. 2012-05-23. PMID:22192379. |
in addition, effects on the brain serotonergic and dopaminergic neurotransmitter systems after agonistic interaction are well studied in many species, but not in zebrafish. |
2012-05-23 |
2023-08-12 |
zebrafish |
| Carlos B Mantilla, Jeffrey P Bailey, Wen-Zhi Zhan, Gary C Siec. Phrenic motoneuron expression of serotonergic and glutamatergic receptors following upper cervical spinal cord injury. Experimental neurology. vol 234. issue 1. 2012-04-19. PMID:22227062. |
phrenic motoneurons express multiple serotonergic (5-htr) and glutamatergic (glur) receptors, but the timing and possible role of these different neurotransmitter receptor subtypes in the neuroplasticity following sh are not clear. |
2012-04-19 |
2023-08-12 |
rat |
| Carlos B Mantilla, Jeffrey P Bailey, Wen-Zhi Zhan, Gary C Siec. Phrenic motoneuron expression of serotonergic and glutamatergic receptors following upper cervical spinal cord injury. Experimental neurology. vol 234. issue 1. 2012-04-19. PMID:22227062. |
the current study was designed to test the hypothesis that there is an increased expression of serotonergic and glutamatergic neurotransmitter receptors within phrenic motoneurons after sh. |
2012-04-19 |
2023-08-12 |
rat |
| Mindy R Waite, Kaia Skaggs, Parisa Kaviany, Jennifer M Skidmore, Frédéric Causeret, James F Martin, Donna M Marti. Distinct populations of GABAergic neurons in mouse rhombomere 1 express but do not require the homeodomain transcription factor PITX2. Molecular and cellular neurosciences. vol 49. issue 1. 2012-04-05. PMID:21925604. |
neurons with distinct neurotransmitter phenotypes have been identified in ventral r1 including gabaergic, serotonergic, and cholinergic neurons. |
2012-04-05 |
2023-08-12 |
mouse |
| Marios Politis, Clare Loan. Serotonergic dysfunction in Parkinson's disease and its relevance to disability. TheScientificWorldJournal. vol 11. 2012-03-27. PMID:22125431. |
results from biochemical, animal, postmortem, and functional imaging studies have revealed that other neurotransmitter systems are affected as well, including the serotonergic system. |
2012-03-27 |
2023-08-12 |
Not clear |
| Agnieszka Permoda-Osip, Janusz Rybakowsk. [Glutamatergic conception of mood disorders]. Psychiatria polska. vol 45. issue 6. 2012-03-06. PMID:22335130. |
the neurotransmitter theories of the pathogenesis and treatment of mood disorders presented so far focused mainly on serotonergic and catecholaminergic (noradrenergic and dopaminergic) transmission. |
2012-03-06 |
2023-08-12 |
Not clear |
| Daniel Collerton, Elaine Perr. Dreaming and hallucinations - continuity or discontinuity? Perspectives from dementia with Lewy bodies. Consciousness and cognition. vol 20. issue 4. 2012-02-24. PMID:21531149. |
variations in cholinergic, dopaminergic and serotonergic neurotransmitter function during sleep and during hallucinations in lewy body dementias, together with relevant drug effects suggest that, on the whole, different, potentially opposite, changes characterise the two states. |
2012-02-24 |
2023-08-12 |
Not clear |
| A Klomp, J L Tremoleda, M Wylezinska, A J Nederveen, M Feenstra, W Gsell, L Renema. Lasting effects of chronic fluoxetine treatment on the late developing rat brain: age-dependent changes in the serotonergic neurotransmitter system assessed by pharmacological MRI. NeuroImage. vol 59. issue 1. 2012-02-13. PMID:21840402. |
lasting effects of chronic fluoxetine treatment on the late developing rat brain: age-dependent changes in the serotonergic neurotransmitter system assessed by pharmacological mri. |
2012-02-13 |
2023-08-12 |
rat |
| Ulla Knorr, Maj Vinberg, Allan Hansen, Marianne Klose, Ulla Feldt-Rasmussen, Linda Hilsted, Jørgen Hasselstrøm, Ulrik Gether, Per Winkel, Christian Gluud, Jørn Wetterslev, Lars Vedel Kessin. Escitalopram and neuroendocrine response in healthy first-degree relatives to depressed patients--a randomized placebo-controlled trial. PloS one. vol 6. issue 6. 2011-12-01. PMID:21738622. |
the serotonergic neurotransmitter system and the hypothalamic-pituitary-adrenal (hpa) system may interact. |
2011-12-01 |
2023-08-12 |
Not clear |